ProfileGDS4718 / 206959_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 64% 62% 58% 63% 69% 68% 61% 60% 59% 61% 63% 64% 76% 62% 62% 63% 69% 65% 71% 62% 61% 60% 63% 57% 74% 61% 73% 66% 70% 62% 70% 52% 61% 69% 74% 65% 61% 62% 71% 62% 73% 61% 74% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9610557
GSM549102patient 115, normal, homogenized [OPG study]6.4146364
GSM549104patient 119, normal, homogenized [OPG study]6.3279762
GSM549108patient 138, normal, homogenized [OPG study]6.0358158
GSM549119patient 077, normal, homogenized [OPG study]6.3377163
GSM549133patient 032, cancer, homogenized [OPG study]6.7967669
GSM549139patient 042, cancer, homogenized [OPG study]6.7136668
GSM549099patient 107, normal, homogenized [OPG study]6.1593961
GSM549109patient 139, normal, homogenized [OPG study]6.1258460
GSM549110patient 046, normal, homogenized [OPG study]6.0357259
GSM549114patient 063, normal, homogenized [OPG study]6.1349461
GSM549122patient 082, normal, homogenized [OPG study]6.3573763
GSM549134patient 033, cancer, homogenized [OPG study]6.3984464
GSM549136patient 036, cancer, homogenized [OPG study]7.5302376
GSM549140patient 044, cancer, homogenized [OPG study]6.2743162
GSM549111patient 047, normal, homogenized [OPG study]6.2848162
GSM549113patient 057, normal, homogenized [OPG study]6.2901363
GSM549132patient 031, cancer, homogenized [OPG study]6.8455269
GSM549137patient 038, cancer, homogenized [OPG study]6.528465
GSM549142patient 047, cancer, homogenized [OPG study]6.8971271
GSM549100patient 110, normal, homogenized [OPG study]6.2262262
GSM549107patient 135, normal, homogenized [OPG study]6.1614561
GSM549115patient 068, normal, homogenized [OPG study]6.1192560
GSM549116patient 072, normal, homogenized [OPG study]6.3280663
GSM549120patient 078, normal, homogenized [OPG study]5.9513657
GSM549131patient 030, cancer, homogenized [OPG study]7.2957574
GSM549118patient 074, normal, homogenized [OPG study]6.1795761
GSM549129patient 027, cancer, homogenized [OPG study]7.2051873
GSM549123patient 088, normal, homogenized [OPG study]6.5836766
GSM549124patient 006, cancer, homogenized [OPG study]6.8104270
GSM549126patient 015, cancer, homogenized [OPG study]6.2218262
GSM549128patient 025, cancer, homogenized [OPG study]6.9599770
GSM549103patient 117, normal, homogenized [OPG study]5.7007652
GSM549117patient 073, normal, homogenized [OPG study]6.1344461
GSM549138patient 041, cancer, homogenized [OPG study]6.8399969
GSM549141patient 045, cancer, homogenized [OPG study]7.3107374
GSM549130patient 028, cancer, homogenized [OPG study]6.5075465
GSM549101patient 111, normal, homogenized [OPG study]6.2158261
GSM549105patient 128, normal, homogenized [OPG study]6.2716562
GSM549106patient 134, normal, homogenized [OPG study]7.0745171
GSM549112patient 048, normal, homogenized [OPG study]6.2857662
GSM549125patient 011, cancer, homogenized [OPG study]7.089873
GSM549127patient 024, cancer, homogenized [OPG study]6.2360161
GSM549135patient 035, cancer, homogenized [OPG study]7.3504274